{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:10:50Z","timestamp":1791411050534,"version":"4.3.3"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.2215\/cjn.02640310","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T21:11:23Z","timestamp":1274994683000},"page":"1710-1716","source":"Crossref","is-referenced-by-count":136,"title":["Fibroblast Growth Factor 23 and Disordered Vitamin D Metabolism in Chronic Kidney Disease"],"prefix":"10.2215","volume":"5","author":[{"given":"Orlando M.","family":"Guti\u00e9rrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-28-20230601","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R2-28-20230601","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","article-title":"Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency","volume":"44","author":"Shigematsu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R3-28-20230601","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"R4-28-20230601","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"R5-28-20230601","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/ndt\/gfp191","article-title":"High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R6-28-20230601","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.atherosclerosis.2009.01.001","article-title":"Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community","volume":"205","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"key":"R7-28-20230601","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","article-title":"Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population","volume":"207","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"key":"R8-28-20230601","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"R9-28-20230601","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","article-title":"Vitamin D levels and patient outcome in chronic kidney disease","volume":"75","author":"Ravani","year":"2009","journal-title":"Kidney Int"},{"key":"R10-28-20230601","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"72","author":"Wolf","year":"2007","journal-title":"Kidney Int"},{"key":"R11-28-20230601","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/archinte.168.15.1629","article-title":"25-hydroxyvitamin D levels and the risk of mortality in the general population","volume":"168","author":"Melamed","year":"2008","journal-title":"Arch Intern Med"},{"key":"R12-28-20230601","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/ki.2009.288","article-title":"Chronic kidney disease, hypovitaminosis D, and mortality in the United States","volume":"76","author":"Mehrotra","year":"2009","journal-title":"Kidney Int"},{"key":"R13-28-20230601","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/ajcn\/87.6.1631","article-title":"Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: A 3-y prospective cohort study","volume":"87","author":"Wang","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"R14-28-20230601","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinternmed.2007.110","article-title":"Association of activated vitamin D treatment and mortality in chronic kidney disease","volume":"168","author":"Kovesdy","year":"2008","journal-title":"Arch Intern Med"},{"key":"R15-28-20230601","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.ki.5001542","article-title":"Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study","volume":"70","author":"Melamed","year":"2006","journal-title":"Kidney Int"},{"key":"R16-28-20230601","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"key":"R17-28-20230601","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: A historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R18-28-20230601","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(08)60251-2","article-title":"Activated vitamin D sterols in kidney disease","volume":"371","author":"Thadhani","year":"2008","journal-title":"Lancet"},{"key":"R19-28-20230601","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1126\/science.176.4039.1146","article-title":"1,25-Dihydroxycholecalciferol: Metabolite of vitamin D3 active on bone in anephric rats","volume":"176","author":"Holick","year":"1972","journal-title":"Science"},{"key":"R20-28-20230601","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1073\/pnas.80.6.1746","article-title":"Do tissues other than the kidney produce 1,25-dihydroxyvitamin D3 in vivo? A reexamination","volume":"80","author":"Shultz","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-28-20230601","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0272-6386(95)90541-3","article-title":"Secondary hyperparathyroidism in renal failure: The trade-off hypothesis revisited","volume":"25","author":"Llach","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"R22-28-20230601","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1210\/jcem-61-4-601","article-title":"On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency","volume":"61","author":"Llach","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-28-20230601","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0003-9861(73)90010-6","article-title":"The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus","volume":"154","author":"Tanaka","year":"1973","journal-title":"Arch Biochem Biophys"},{"key":"R24-28-20230601","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ki.1982.9","article-title":"Circulating vitamin D metabolite concentrations in childhood renal diseases","volume":"21","author":"Chesney","year":"1982","journal-title":"Kidney Int"},{"key":"R25-28-20230601","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0272-6386(97)90330-9","article-title":"The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure","volume":"29","author":"Martinez","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"R26-28-20230601","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/jcem-67-5-876","article-title":"Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure","volume":"67","author":"Pitts","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-28-20230601","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/ki.1982.70","article-title":"Reduced plasma concentration of 1,25-dihydroxyvitamin D in children with moderate renal insufficiency","volume":"21","author":"Portale","year":"1982","journal-title":"Kidney Int"},{"key":"R28-28-20230601","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/ndt\/6.3.162","article-title":"Calcium metabolism in early chronic renal failure: Implications for the pathogenesis of hyperparathyroidism","volume":"6","author":"Reichel","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"R29-28-20230601","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1172\/JCI111365","article-title":"Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency","volume":"73","author":"Portale","year":"1984","journal-title":"J Clin Invest"},{"key":"R30-28-20230601","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","article-title":"Mineral metabolism parameters throughout chronic kidney disease stages 1\u20135\u2014achievement of K\/DOQI target ranges","volume":"22","author":"Craver","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R31-28-20230601","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/jcem-41-2-339","article-title":"Skeletal resistance to endogenous parathyroid hormone in pateints with early renal failure. A possible cause for secondary hyperparathyroidism","volume":"41","author":"Llach","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-28-20230601","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2007010068","article-title":"How fibroblast growth factor 23 works","volume":"18","author":"Liu","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R33-28-20230601","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R34-28-20230601","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2007060673","article-title":"Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD","volume":"19","author":"Isakova","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R35-28-20230601","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1038\/sj.ki.5002000","article-title":"Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men","volume":"70","author":"Nishida","year":"2006","journal-title":"Kidney Int"},{"key":"R36-28-20230601","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bone.2006.10.016","article-title":"Effects of gonadal steroid withdrawal on serum phosphate and FGF-23 levels in men","volume":"40","author":"Burnett-Bowie","year":"2007","journal-title":"Bone"},{"key":"R37-28-20230601","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00774-007-0779-3","article-title":"Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans","volume":"25","author":"Ito","year":"2007","journal-title":"J Bone Miner Metab"},{"key":"R38-28-20230601","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/ndt\/gfp699","article-title":"Fibroblast growth factor-23 and early decrements in kidney function: The Heart and Soul Study","volume":"25","author":"Ix","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R39-28-20230601","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"R40-28-20230601","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJM197205182862009","article-title":"On the pathogenesis of the uremic state. An exposition of the \u201ctrade-off hypothesis\u201d","volume":"286","author":"Bricker","year":"1972","journal-title":"N Engl J Med"},{"key":"R41-28-20230601","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ki.1973.92","article-title":"The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease","volume":"4","author":"Slatopolsky","year":"1973","journal-title":"Kidney Int"},{"key":"R42-28-20230601","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1172\/JCI106517","article-title":"On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog","volume":"50","author":"Slatopolsky","year":"1971","journal-title":"J Clin Invest"},{"key":"R43-28-20230601","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1681\/ASN.2005040392","article-title":"Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: A prospective, controlled study","volume":"16","author":"Ayus","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R44-28-20230601","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R45-28-20230601","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.167.9.879","article-title":", Gaziano JM, Vasan RS: Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community","volume":"167","author":"Dhingra","year":"2007","journal-title":"Arch Intern Med"},{"key":"R46-28-20230601","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R47-28-20230601","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","article-title":"Relation between serum phosphate level and cardiovascular event rate in people with coronary disease","volume":"112","author":"Tonelli","year":"2005","journal-title":"Circulation"},{"key":"R49-28-20230601","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.RES.81.5.679","article-title":"Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy","volume":"81","author":"Corda","year":"1997","journal-title":"Circ Res"},{"key":"R50-28-20230601","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1161\/01.CIR.0000024113.26985.CC","article-title":"Fibroblast growth factor receptor-1 signaling induces osteopontin expression and vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro","volume":"106","author":"Li","year":"2002","journal-title":"Circulation"},{"key":"R51-28-20230601","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1113\/expphysiol.1998.sp004140","article-title":"Basic fibroblast growth factor induces myocardial hypertrophy following acute infarction in rats","volume":"83","author":"Scheinowitz","year":"1998","journal-title":"Exp Physiol"},{"key":"R52-28-20230601","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2353\/ajpath.2007.070003","article-title":"Fibroblast growth factor-2 regulates myocardial infarct repair: Effects on cell proliferation, scar contraction, and ventricular function","volume":"171","author":"Virag","year":"2007","journal-title":"Am J Pathol"},{"key":"R53-28-20230601","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1210\/en.2005-0670","article-title":"Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23","volume":"146","author":"Yu","year":"2005","journal-title":"Endocrinology"},{"key":"R54-28-20230601","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/HYPERTENSIONAHA.108.119602","article-title":"Expression of the vitamin D receptor is increased in the hypertrophic heart","volume":"52","author":"Chen","year":"2008","journal-title":"Hypertension"},{"key":"R55-28-20230601","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1172\/JCI114097","article-title":"Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries","volume":"83","author":"Merke","year":"1989","journal-title":"J Clin Invest"},{"key":"R56-28-20230601","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MAJ.0b013e3181815498","article-title":"Fibroblast growth factor 23: A possible cause of left ventricular hypertrophy in hemodialysis patients","volume":"337","author":"Hsu","year":"2009","journal-title":"Am J Med Sci"},{"key":"R57-28-20230601","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R58-28-20230601","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1093\/ndt\/gfp205","article-title":"Relationship between circulating FGF23 and total body atherosclerosis in the community","volume":"24","author":"Mirza","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R59-28-20230601","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ndt\/gfn571","article-title":"Peripheral vascular calcification in long-haemodialysis patients: Associated factors and survival consequences","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R61-28-20230601","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/002215549704500710","article-title":"Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues","volume":"45","author":"Hughes","year":"1997","journal-title":"J Histochem Cytochem"},{"key":"R62-28-20230601","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2006-0021","article-title":"Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men","volume":"91","author":"Antoniucci","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R63-28-20230601","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","article-title":"Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women","volume":"21","author":"Burnett","year":"2006","journal-title":"J Bone Miner Res"},{"key":"R64-28-20230601","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","article-title":"Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men","volume":"90","author":"Ferrari","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R65-28-20230601","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1744-9987.2005.00293.x","article-title":"Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients","volume":"9","author":"Koiwa","year":"2005","journal-title":"Ther Apher Dial"},{"key":"R66-28-20230601","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2215\/CJN.05420709","article-title":"Early control of PTH and FGF23 in normophosphatemic CKD patients: A new target in CKD-MBD therapy?","volume":"5","author":"Oliveira","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R67-28-20230601","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"Bonaa","year":"2006","journal-title":"N Engl J Med"},{"key":"R68-28-20230601","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"key":"R69-28-20230601","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R70-28-20230601","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2215\/CJN.03630509","article-title":"Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD","volume":"5","author":"Wetmore","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R71-28-20230601","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1074\/jbc.M408903200","article-title":"Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo","volume":"280","author":"Saito","year":"2005","journal-title":"J Biol Chem"},{"key":"R72-28-20230601","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2215\/CJN.04981107","article-title":"Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets","volume":"3","author":"Alon","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R73-28-20230601","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1210\/jc.2009-1671","article-title":"Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations","volume":"95","author":"Imel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R74-28-20230601","doi-asserted-by":"crossref","first-page":"c94","DOI":"10.1159\/000086347","article-title":"Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism","volume":"101","author":"Nishi","year":"2005","journal-title":"Nephron Clin Pract"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201009000-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:39:47Z","timestamp":1786369187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201009000-00028"}},"subtitle":["Updating the \u201cTrade-off\u201d Hypothesis"],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.02640310","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}